May 20, 2022
May 20, 2022 – Vidaza® (azacytidine) is now approved to treat newly diagnosed juvenile myelomonocytic
leukemia (JMML), a rare form of blood cancer, in pediatric patients
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Health Insurance
May 19, 2022
May 19, 2022 – Tpoxx® (tecovirimat – SIGA Technologies) has received an expanded smallpox treatment
indication, as well as FDA approval of a new dosage formulation
May 17, 2022
May 17, 2022 – The U.S. FDA has expanded emergency use authorization (EUA) for Comirnaty® (COVID-
19 vaccine, mRNA), made by Pfizer and BioNTech.
May 13, 2022
May 13, 2022 – Dupixent® (tirzepatide) has become the first drug to win FDA approval specifically for treating eosinophilic esophagitis (EoE). It is indicated to treat EoE
May 13, 2022
May 13, 2022 – Eli Lilly’s MounjaroTM (tirzepatide) has received FDA approval for use alongside diet and exercise to improve blood sugar control in adults who have type 2 diabetes.
May 12, 2022
May 12, 2022 – Sandoz has launched the first fully substitutable generic for Genentech’s Esbriet® (pirfenidone) tablets. Esbriet is also available in capsule form
May 12, 2022
May 12, 2022 – Radicava ORS® (edaravone – Mitsubishi Tanabe Pharma America), has received FDA approval to treat amyotrophic lateral sclerosis (ALS) in adults.
May 11, 2022
May 11, 2022 – Olumiant® (baricitinib – Eli Lilly and Incyte) is now approved to treat COVID-19 in hospitalized adults who require supplemental oxygen